Cidara Therapeutics, Inc. Underwriting Agreements
6 Contracts & Agreements
- Underwriting Agreement, dated March 3, 2023, by and between Cidara Therapeutics, Inc. and Cantor Fitzgerald & Co. (Series X Convertible Preferred Stock) (Filed With SEC on March 6, 2023)
- Underwriting Agreement, dated March 3, 2023, by and between Cidara Therapeutics, Inc. and Cantor Fitzgerald & Co. (Common Stock) (Filed With SEC on March 6, 2023)
- Underwriting Agreement, dated October 7, 2021, by and between Cidara Therapeutics, Inc. and Cantor Fitzgerald & Co. (Series X Convertible Preferred Stock) (Filed With SEC on October 8, 2021)
- Underwriting Agreement, dated October 7, 2021, by and between Cidara Therapeutics, Inc. and Cantor Fitzgerald & Co. (Common Stock) (Filed With SEC on October 8, 2021)
- 2,475,248 Shares Cidara Therapeutics, Inc. UNDERWRITING AGREEMENT (Filed With SEC on October 7, 2016)
- [Number of Shares] Cidara Therapeutics, Inc. UNDERWRITING AGREEMENT (Filed With SEC on April 6, 2015)
